Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Herrmann

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
Protein Science : a Publication of the Protein Society|November 22, 2016
New insights into interactions between the nucleotide-binding domain of CFTR and keratin 8Aiswarya Premchandar, Anna Kupniewska, Arkadiusz Bonna, et al.
Biophysical Journal|May 15, 2018
Assembly Kinetics of Vimentin Tetramers to Unit-Length Filaments: A Stopped-Flow StudyNorbert Mücke, Lara Kämmerer, Stefan Winheim, et al.
The Journal of Biological Chemistry|January 29, 2013
Nuclear envelope composition determines the ability of neutrophil-type cells to passage through micron-scale constrictionsAmy C Rowat, Diana E Jaalouk, Monika Zwerger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2014
Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AMLKatharina Blatt, Harald Herrmann, Gregor Hoermann, et al.
Blood|March 23, 2012
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligandViviane Ghanim, Harald Herrmann, Gerwin Heller, et al.
Leukemia Research Reports|March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HPeter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Experimental Hematology|June 18, 2010
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816VAlexandra Böhm, Karoline Sonneck, Karoline V Gleixner, et al.
Haematologica|October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHarald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2009
A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organizationPekka Taimen, Katrin Pfleghaar, Takeshi Shimi, et al.
Oncotarget|December 20, 2012
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AMLHarald Herrmann, Katharina Blatt, Junwei Shi, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Protein Science : a Publication of the Protein Society|November 22, 2016
New insights into interactions between the nucleotide-binding domain of CFTR and keratin 8Aiswarya Premchandar, Anna Kupniewska, Arkadiusz Bonna, et al.
Biophysical Journal|May 15, 2018
Assembly Kinetics of Vimentin Tetramers to Unit-Length Filaments: A Stopped-Flow StudyNorbert Mücke, Lara Kämmerer, Stefan Winheim, et al.
The Journal of Biological Chemistry|January 29, 2013
Nuclear envelope composition determines the ability of neutrophil-type cells to passage through micron-scale constrictionsAmy C Rowat, Diana E Jaalouk, Monika Zwerger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2014
Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AMLKatharina Blatt, Harald Herrmann, Gregor Hoermann, et al.
Blood|March 23, 2012
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligandViviane Ghanim, Harald Herrmann, Gerwin Heller, et al.
Leukemia Research Reports|March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HPeter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Experimental Hematology|June 18, 2010
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816VAlexandra Böhm, Karoline Sonneck, Karoline V Gleixner, et al.
Haematologica|October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHarald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2009
A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organizationPekka Taimen, Katrin Pfleghaar, Takeshi Shimi, et al.
Oncotarget|December 20, 2012
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AMLHarald Herrmann, Katharina Blatt, Junwei Shi, et al.
Pageof 24